PIK3CA and neoplasm: As BRAF and PIK3CA mutations tended to co-occur in the ATC tumours, we hypothesized that the introduction of a PIK3CA mutation into a BRAF mutant PTC model would lead to increased aggressiveness and cellular dedifferentiation, mimicking a possible route of progression from PTC to ATC.